Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
filgotinib
Pharma
Galapagos sells its Jyseleca business to Italy's Alfasigma
Galapagos has agreed to sell its Jyseleca business to Alfasigma. Around 400 Galapagos employees will join the Italian company under the deal.
Kevin Dunleavy
Oct 31, 2023 9:10am
Galapagos slashes Jyseleca sales projection, scraps submissions
Aug 4, 2023 11:12am
Galapagos' Jyseleca can't prove its worth in Crohn's disease
Feb 9, 2023 11:36am
Doctors like AbbVie's Rinvoq in IBD, but not Bristol's Zeposia
Feb 22, 2021 11:17am
Gilead guts its filgotinib plans—and CEO's rebuild along with it
Dec 16, 2020 10:54am
CStone-Pfizer, Gilead, Takeda-Ovid and more—FiercePharmaAsia
Oct 2, 2020 9:10am
